Morristown Medical Center officially names Fiel chief medical officer

Has served as interim CMO since May 2022

Dr. Stanley Fiel has been named chief medical officer of Atlantic Health System’s Morristown Medical Center. Fiel has served as interim CMO since May 2022.

“We are honored that Dr. Fiel will continue to play a highly instrumental medical leadership role at Morristown Medical Center,” Trish O’Keefe, president, Morristown Medical Center, and senior vice president and chief nurse executive, Atlantic Health System, said.

“Dr. Fiel’s leadership during this time has been invaluable. He has guided and collaborated with our medical and nursing staff throughout the COVID pandemic and recent pediatric respiratory surges, skillfully leading our team during challenging, high-volume periods at our hospital.”

Fiel has served as the chairman for the Department of Medicine and as a leading physician at Morristown Medical Center for nearly 20 years and is an experienced and accomplished clinician, educator and researcher. Fiel is also professor of medicine, Sidney Kimmel Medical College at Thomas Jefferson University, and is the author of numerous published works and an active member of local and national societies.

“Witnessing the impact of the compassionate care demonstrated by our health care teams here, I am reminded every day to seek out and strengthen my connections with my patients, their families and all of the staff that support the care we provide to our community,” Fiel said. “For those of us at Morristown Medical Center and Atlantic Health System, we see our responsibility to deliver unparalleled health care and to elevate our reputation for extraordinary care.”

Since 1978, Fiel has held key hospital appointments, including chief of the division of Pulmonary/Critical Care Medicine at Drexel University College of Medicine and Hahnemann University in Philadelphia.

A fellow of the American College of Chest Physicians and the American College of Physicians, Fiel also is a member of the American Thoracic Society and other professional societies. He has served on the editorial boards for journals such as the Journal of Asthma, Chest, and Clinical Pulmonary Medicine.

Fiel’s many contributions to medical literature have appeared in publications such as the New England Journal of Medicine, the Journal of the American Medical Association, the American Journal of Respiratory and Critical Care Medicine, and Chest. His major research interests include the mechanisms of inflammation in cystic fibrosis and therapeutic advances in the treatment of obstructive pulmonary disorders including asthma, cystic fibrosis, bronchiectasis and chronic obstructive pulmonary disease. He has published more than 200 articles, abstracts, chapters and monographs in the medical literature.